Sensitivity	sensitivity	O	O
of	of	O	O
erythroid	erythroid	O	O
progenitor	progenitor	O	O
colonies	colonies	O	O
to	to	O	O
erythropoietin	erythropoietin	O	O
in	in	O	O
azidothymidine	azidothymidine	S_chemicals	O
treated	treated	O	O
immunodeficient	immunodeficient	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
anaemia	anaemia	O	O
induced	induced	O	O
by	by	O	O
3'-azido-3'dideoxythymidine	3'-azido-3'dideoxythymidine	O	O
(	(	O	O
AZT	azt	O	O
)	)	O	O
is	is	O	O
poorly	poorly	O	O
understood	understood	O	O
.	.	O	O

We	we	O	O
have	have	O	O
used	used	O	O
a	a	O	O
murine	murine	O	O
model	model	O	O
of	of	O	O
AIDS	aids	O	S_disease
,	,	O	O
infection	infection	O	S_disease
of	of	O	O
female	female	O	O
C57BL/6	c57bl/6	O	O
mice	mice	O	O
with	with	O	O
LP-BM5	lp-bm5	O	O
murine	murine	O	O
leukaemia	leukaemia	O	O
(	(	O	O
MuLV	mulv	O	O
)	)	O	O
virus	virus	O	O
,	,	O	O
to	to	O	O
determine	determine	O	O
if	if	O	O
AZT-induced	azt-induced	O	O
anaemia	anaemia	O	O
is	is	O	O
due	due	O	O
,	,	O	O
in	in	O	O
part	part	O	O
,	,	O	O
to	to	O	O
decreased	decreased	O	O
responsiveness	responsiveness	O	O
of	of	O	O
erythropoietic	erythropoietic	O	O
precursors	precursors	O	O
(	(	O	O
BFU-e	bfu-e	O	O
)	)	O	O
to	to	O	O
erythropoietin	erythropoietin	O	O
(	(	O	O
EPO	epo	O	O
)	)	O	O
.	.	O	O

Mice	mice	O	O
in	in	O	O
the	the	O	O
early	early	O	O
stage	stage	O	O
of	of	O	O
LP-BM5	lp-bm5	O	O
MuLV	mulv	O	O
disease	disease	O	S_disease
were	were	O	O
given	given	O	O
AZT	azt	O	O
in	in	O	O
their	their	O	O
drinking	drinking	B_chemicals	O
water	water	S_chemicals	O
at	at	O	O
1.0	1.0	O	O
and	and	O	O
2.5	2.5	O	O
mg/ml	mg/ml	O	O
.	.	O	O

AZT	azt	O	O
produced	produced	O	O
anaemia	anaemia	O	O
in	in	O	O
both	both	O	O
groups	groups	O	O
,	,	O	O
in	in	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
fashion	fashion	O	O
.	.	O	O

Despite	despite	O	O
the	the	O	O
anaemia	anaemia	O	O
,	,	O	O
the	the	O	O
number	number	O	O
of	of	O	O
splenic	splenic	O	O
and	and	O	O
bone	bone	O	B_disease
marrow	marrow	O	I_disease
BFU-e	bfu-e	O	O
in	in	O	O
AZT	azt	O	O
treated	treated	O	O
mice	mice	O	O
increased	increased	O	O
up	up	O	O
to	to	O	O
five-fold	five-fold	O	O
over	over	O	O
levels	levels	O	O
observed	observed	O	O
in	in	O	O
infected	infected	O	O
untreated	untreated	O	O
animals	animals	O	O
after	after	O	O
15	15	O	O
d	d	O	O
of	of	O	O
treatment	treatment	O	O
.	.	O	O

Colony	colony	O	O
formation	formation	O	O
by	by	O	O
splenic	splenic	O	O
and	and	O	O
bone	bone	O	B_disease
marrow	marrow	O	I_disease
BFUe	bfue	O	O
was	was	O	O
stimulated	stimulated	O	O
at	at	O	O
lower	lower	O	O
concentrations	concentrations	O	O
of	of	O	O
EPO	epo	O	O
in	in	O	O
mice	mice	O	O
receiving	receiving	O	O
AZT	azt	O	O
for	for	O	O
15	15	O	O
d	d	O	O
than	than	O	O
for	for	O	O
infected	infected	O	O
,	,	O	O
untreated	untreated	O	O
mice	mice	O	O
.	.	O	O

By	by	O	O
day	day	O	O
30	30	O	O
,	,	O	O
sensitivity	sensitivity	O	O
of	of	O	O
both	both	O	O
splenic	splenic	O	O
and	and	O	O
bone	bone	O	B_disease
marrow	marrow	O	I_disease
BFU-e	bfu-e	O	O
of	of	O	O
treated	treated	O	O
animals	animals	O	O
returned	returned	O	O
to	to	O	O
that	that	O	O
observed	observed	O	O
from	from	O	O
cells	cells	O	O
of	of	O	O
infected	infected	O	O
untreated	untreated	O	O
animals	animals	O	O
.	.	O	O

The	the	O	O
mean	mean	O	O
plasma	plasma	O	O
levels	levels	O	O
of	of	O	O
EPO	epo	O	O
observed	observed	O	O
in	in	O	O
AZT	azt	O	O
treated	treated	O	O
mice	mice	O	O

were	were	O	O
appropriate	appropriate	O	O
for	for	O	O
the	the	O	O
degree	degree	O	O
of	of	O	O
anaemia	anaemia	O	O
observed	observed	O	O
when	when	O	O
compared	compared	O	O
with	with	O	O
phenylhydrazine	phenylhydrazine	O	O
(	(	O	O
PHZ	phz	O	O
)	)	O	O
treated	treated	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
numbers	numbers	O	O
of	of	O	O
BFU-e	bfu-e	O	O
and	and	O	O
the	the	O	O
percentage	percentage	O	O
of	of	O	B_disease
bone	bone	O	B_disease
marrow	marrow	O	I_disease
erythroblasts	erythroblasts	O	O
observed	observed	O	O
were	were	O	O
comparable	comparable	O	O
in	in	O	O
AZT	azt	O	O
and	and	O	O
PHZ	phz	O	O
treated	treated	O	O
mice	mice	O	O
with	with	O	O
similar	similar	O	O
degrees	degrees	O	O
of	of	O	O
anaemia	anaemia	O	O
.	.	O	O

However	however	O	O
,	,	O	O
reticulocytosis	reticulocytosis	O	S_disease
was	was	O	O
inappropriate	inappropriate	O	O
for	for	O	O
the	the	O	O
degree	degree	O	O
of	of	O	O
anaemia	anaemia	O	O
observed	observed	O	O
in	in	O	O
AZT	azt	O	O
treated	treated	O	O
infected	infected	O	O
mice	mice	O	O
.	.	O	O

AZT-induced	azt-induced	O	O
peripheral	peripheral	O	O
anaemia	anaemia	O	O
in	in	O	O
the	the	O	O
face	face	O	O
of	of	O	O
increased	increased	O	O
numbers	numbers	O	O
of	of	O	O
BFU-e	bfu-e	O	O
and	and	O	O
increased	increased	O	O
levels	levels	O	O
of	of	O	O
plasma	plasma	O	O
EPO	epo	O	O
suggest	suggest	O	O
a	a	O	O
lesion	lesion	O	O
in	in	O	O
terminal	terminal	O	O
differentiation	differentiation	O	O
.	.	O	O

